← Back to Patent Explorer
US4289850A Expired / Lapsed US ⏱️ 0.0 years remaining

Interferon production

Assignee: Beecham Group PLC
•
Filing: 1980-01-10
•
Granted: 1981-09-15
•
Expires: 2000-01-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for preparing interferon in which MRC-5 cells are induced for 2 to 3 hours with an interferon-inducing medium containing from 0.1 to 50 mg 1 -1 of a ds-RNA, 100 mg 1 -1 of DEAE-Dextran and 250 m.M of sucrose. Other sugars which can be used include glucose, galactose, fructose, mannose and maltose, and a preferred ds-RNA is naturally occurring ds-RNA isolated from P. chrysogenum.

Inventors

  • 👤 Jeffery H. Robinson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 11:38
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/52; C07K14/555; C12; C12N; C12N1/00; C12P; C12P21/00; C12R; C12R2001/00; C12R2001/91; Y; Y10; Y10S; Y10S435/00; Y10S435/811; Y10S435/8215; Y10S435/948

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 63 words
A method for preparing interferon, in which interferon-producing cells are contacted in vitro with an interferon-inducing medium comprising a non-toxic quantity of an interferon-inducing double-stranded polynucleotide, diethylamine ethyl dextran (DEAE-Dextran), and at least 100 m.mol 1 -1 of a water soluble sugar in a physiologically acceptable aqueous vehicle at physiological conditions of temperature and pH, and the interferon so formed is thereafter separated.
Claim 2
Independent Claim 63 words
A method for preparing interferon, in which interferon-producing cells are contacted in vitro with an interferon-inducing medium comprising a non-toxic quantity of an interferon-inducing double-stranded polynucleotide, diethylamine ethyl dextran (DEAE-Dextran), and at least 100 m.mol 1 -1 of a water soluble sugar in a physiologically acceptable aqueous vehicle at physiological conditions of temperature and pH, and the interferon so formed is thereafter separated.
Claim 3
Dependent Claim 21 words
A method according to claim 1, wherein the amount of sugar present is from 200 to 500 m.mol 1 -1 .
Claim 4
Dependent Claim 17 words
A method according to claim 1, wherein the sugar is glucose, galactose, sucrose, fructose, mannose or maltose.
Claim 5
Dependent Claim 15 words
A method according to claim 1, wherein the double-stranded polynucleotide is a naturally occurring ds-RNA.
Claim 6
Dependent Claim 15 words
A method according to claim 4, characterised in that the ds-RNA is isolated from P-chrysogenum.
Claim 7
Dependent Claim 26 words
A method according to claim 1, wherein the concentration of the double-stranded polynucleotide is in the range of from 0.1 to 50 mg 1 -1 .
Claim 8
Dependent Claim 24 words
A method according to claim 1, wherein the concentration of DEAE-Dextran in the inducing medium is from 100 to 300 mg 1 -1 .
Claim 9
Dependent Claim 26 words
A method according to claim 1, wherein an appropriate quantity of cells is first cultured, and thereafter the cultured cells are treated with the interferon-inducing medium.
Claim 10
Dependent Claim 17 words
A method according to claim 8, wherein the cells are leucocytes, epithelial cells, fibroblasts or diploid fibroblasts.

References Cited (Backward Citations)

US4007086A Cited
US4144126A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-09-14 1985-03-16 1985-09-15 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-09-14 1989-03-16 1989-09-15 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-09-14 1993-03-16 1993-09-15 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag